` 539997 (Kwality Pharmaceuticals Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

539997
vs
B
BSE Sensex 30

Over the past 12 months, KPL has outperformed BSE Sensex 30, delivering a return of +20% compared to the BSE Sensex 30's +9% growth.

Stocks Performance
539997 vs BSE Sensex 30

Loading
539997
BSE Sensex 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
539997 vs BSE Sensex 30

Loading
539997
BSE Sensex 30
Difference
www.alphaspread.com

Performance By Year
539997 vs BSE Sensex 30

Loading
539997
BSE Sensex 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Kwality Pharmaceuticals Ltd vs Peers

BSE Sensex 30
539997
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Kwality Pharmaceuticals Ltd
Glance View

Market Cap
11.7B INR
Industry
Pharmaceuticals

Kwality Pharmaceuticals Pvt Ltd. engages in the manufacture of pharmaceutical formulations in dosage form. The company is headquartered in Amritsar, Punjab. The company went IPO on 2016-07-18. The firm operates through the segment of manufacturing a range of finished pharmaceutical formulations in a dosage form, such as tablets, liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations and oral rehydration solutions (ORS), among others. The company provides pharmaceutical formulations in various categories, such as beta-lactam and non-beta lactam, hormones and cytotoxic (oncology). The company manufactures beta-lactam and cephalosporin molecules in various dosage forms, such as tablets, capsules, dry powder for suspension and dry powder for injection. The company manufactures the anticancer products in various dosage forms, such as tablets, capsules and injectables. Its products are available in Europe, Africa and Asian countries, among others.

KPL Intrinsic Value
673.54 INR
Overvaluation 40%
Intrinsic Value
Price
Back to Top